Cargando…
mRNA as novel technology for passive immunotherapy
While active immunization elicits a lasting immune response by the body, passive immunotherapy transiently equips the body with exogenously generated immunological effectors in the form of either target-specific antibodies or lymphocytes functionalized with target-specific receptors. In either case,...
Autores principales: | Schlake, Thomas, Thess, Andreas, Thran, Moritz, Jordan, Ingo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339677/ https://www.ncbi.nlm.nih.gov/pubmed/30334070 http://dx.doi.org/10.1007/s00018-018-2935-4 |
Ejemplares similares
-
mRNA mediates passive vaccination against infectious agents, toxins, and tumors
por: Thran, Moritz, et al.
Publicado: (2017) -
Optimised Non-Coding Regions of mRNA SARS-CoV-2 Vaccine CV2CoV Improves Homologous and Heterologous Neutralising Antibody Responses
por: Roth, Nicole, et al.
Publicado: (2022) -
Sequence-engineered mRNA Without Chemical Nucleoside Modifications Enables an Effective Protein Therapy in Large Animals
por: Thess, Andreas, et al.
Publicado: (2015) -
Advancements in mRNA Encoded Antibodies for Passive Immunotherapy
por: Deal, Cailin E., et al.
Publicado: (2021) -
A novel, disruptive vaccination technology: Self-adjuvanted RNActive(®) vaccines
por: Kallen, Karl-Josef, et al.
Publicado: (2013)